HF
TSVT

Halpern Financial’s 2seventy bio TSVT Stock Holding History

Halpern Financial’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$481 Hold
100
– – ﹤0.01% 218
2024
Q2 		$385 Hold
100
– – ﹤0.01% 210
2024
Q1 		$498 Sell
100
-66
-40% -$310 ﹤0.01% 202
2023
Q4 		$637 Buy
+166
New +$510 ﹤0.01% 235

Other funds holding TSVT

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Halpern Financial's TSVT Position: Q3 2024 in Review

Halpern Financial held its 2seventy bio (TSVT) position steady in Q3 2024 at 100 shares worth $481. The position accounts for ﹤0.01% of the portfolio, ranked #218.

Halpern Financial first reported a position in TSVT in Q4 2023 and has held it in 4 quarters since. The position peaked at $637 in Q4 2023. 115 funds tracked by Wall St. Rank hold TSVT as of Q3 2024.

  • Halpern Financial held 100 shares of 2seventy bio worth $481 as of Q3 2024.
  • Halpern Financial left its 2seventy bio share count unchanged in Q3 2024.
  • 2seventy bio made up ﹤0.01% of Halpern Financial's portfolio in Q3 2024, its #218 holding.
  • Halpern Financial first reported a position in 2seventy bio in Q4 2023 and has held it in 4 quarters since.
  • Halpern Financial's 2seventy bio position peaked at $637 in Q4 2023.
  • 115 funds tracked by Wall St. Rank held 2seventy bio as of Q3 2024.

Based on Halpern Financial's 13F filing for Q3 2024, filed 4 Oct 2024.